Combination of Ca2+ -activated K+ channel blockers inhibits acetylcholine-evoked nitric oxide release in rat superior mesenteric artery

Br J Pharmacol. 2006 Nov;149(5):560-72. doi: 10.1038/sj.bjp.0706886. Epub 2006 Sep 11.

Abstract

Background and purpose: The present study investigated whether calcium-activated K+ channels are involved in acetylcholine-evoked nitric oxide (NO) release and relaxation.

Experimental approach: Simultaneous measurements of NO concentration and relaxation were performed in rat superior mesenteric artery and endothelial cell membrane potential and intracellular calcium ([Ca2+]i) were measured.

Key results: A combination of apamin plus charybotoxin, which are, respectively, blockers of small-conductance and of intermediate- and large-conductance Ca2+ -activated K channels abolished acetylcholine (10 microM)-evoked hyperpolarization of endothelial cell membrane potential. Acetylcholine-evoked NO release was reduced by 68% in high K+ (80 mM) and by 85% in the presence of apamin plus charybdotoxin. In noradrenaline-contracted arteries, asymmetric dimethylarginine (ADMA), an inhibitor of NO synthase inhibited acetylcholine-evoked NO release and relaxation. However, only further addition of oxyhaemoglobin or apamin plus charybdotoxin eliminated the residual acetylcholine-evoked NO release and relaxation. Removal of extracellular calcium or an inhibitor of calcium influx channels, SKF96365, abolished acetylcholine-evoked increase in NO concentration and [Ca2+]i. Cyclopiazonic acid (CPA, 30 microM), an inhibitor of sarcoplasmic Ca2+ -ATPase, caused a sustained NO release in the presence, but only a transient increase in the absence, of extracellular calcium. Incubation with apamin and charybdotoxin did not change acetylcholine or CPA-induced increases in [Ca2+]i, but inhibited the sustained NO release induced by CPA.

Conclusions and implications: Acetylcholine increases endothelial cell [Ca2+]i by release of stored calcium and calcium influx resulting in activation of apamin and charybdotoxin-sensitive K channels, hyperpolarization and release of NO in the rat superior mesenteric artery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology*
  • Animals
  • Apamin / pharmacology
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Barium Compounds / pharmacology
  • Benzimidazoles / pharmacology
  • Calcium / metabolism
  • Charybdotoxin / pharmacology
  • Chlorides / pharmacology
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / physiology
  • Imidazoles / pharmacology
  • In Vitro Techniques
  • Indoles / pharmacology
  • Indomethacin / pharmacology
  • Male
  • Mesenteric Artery, Superior / drug effects*
  • Mesenteric Artery, Superior / metabolism
  • Mesenteric Artery, Superior / physiology
  • Nitric Oxide / metabolism*
  • Oxyhemoglobins / pharmacology
  • Penicillamine / analogs & derivatives
  • Penicillamine / pharmacology
  • Potassium Channels, Calcium-Activated / antagonists & inhibitors*
  • Potassium Channels, Calcium-Activated / physiology
  • Rats
  • Rats, Wistar
  • Vasodilation / drug effects
  • Vasodilation / physiology
  • Vasodilator Agents / pharmacology

Substances

  • Barium Compounds
  • Benzimidazoles
  • Chlorides
  • Imidazoles
  • Indoles
  • Oxyhemoglobins
  • Potassium Channels, Calcium-Activated
  • S-nitro-N-acetylpenicillamine
  • Vasodilator Agents
  • dimethylarginine
  • barium chloride
  • Charybdotoxin
  • Apamin
  • Nitric Oxide
  • Arginine
  • Penicillamine
  • 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole
  • 1-ethyl-2-benzimidazolinone
  • Acetylcholine
  • Calcium
  • cyclopiazonic acid
  • Indomethacin